
Project Type
Company Name
Related Industry
Description
1. Problem Statement
Pharmaceutical companies face inefficiencies in field operations due to manual tour planning, delayed approvals, and lack of real-time tracking for Medical Representatives (MRs). Disconnected workflows lead to compliance risks, unproductive doctor visits, and poor expense management. The absence of a centralized system caused data silos, approval bottlenecks, and limited visibility into MR activities, impacting sales performance and operational transparency.
2. Solution Provided
• Automated Approval Workflows: Hierarchical approvals (ASM/RSM/ZSM) for tour plans, expenses, and sample requests to ensure compliance.
• Real-Time Field Monitoring: GPS-enabled tour tracking with offline sync for uninterrupted data capture.
• Centralized Master Data: Unified management of doctors, chemists, and stockists with role-based access controls.
• AI-Driven Analytics: Dashboards with sales trends, performance metrics, and heatmaps for high-potential zones.
• Mobile-First Approach: Android/iOS apps for MRs to log visits, submit expenses, and request samples on the go.
• Automated Notifications: Alerts for pending approvals, schedule changes, and policy violations.
• Inventory & Sample Management: End-to-end tracking of sample distribution with threshold alerts.
• Seamless Integrations: APIs for CRM, HRMS, and accounting systems to eliminate data redundancy.
• Audit-Ready Reports: Exportable compliance logs for financial and regulatory reviews.
3. Business Impact
The ERP reduced approval turnaround time by 60%, accelerating MR productivity. Automated tour plans improved visit efficiency by 40%, while real-time analytics enhanced decision-making for managers. Sample request processing time dropped by 50%, and expense frauds were reduced through receipt validations. The system ensured 100% compliance with audit trails, cutting regulatory risks. Scalable for 5,000+ users, it delivered 30% higher ROI within a year by optimizing resource allocation and minimizing operational delays.